acut
respiratori
tract
infect
common
infecti
diseas
among
children
incid
communityacquir
pneumonia
europ
age
group
year
clinic
manifest
includ
symptom
rang
mild
rhiniti
sever
pneumonia
lead
respiratori
failur
risk
group
sever
diseas
cours
includ
children
year
age
especi
boy
individu
immunosuppress
patient
suffer
chronic
diseas
establish
etiolog
factor
difficult
task
clinic
radiolog
biochem
marker
would
enabl
differenti
bacteri
viral
infect
frequent
result
overus
antibiot
therapi
acut
respiratori
infect
british
american
polish
guidelin
state
children
hospit
due
pneumonia
microbiolog
examin
includ
blood
cultur
detect
presenc
virus
use
pcr
polymeras
chain
reaction
immunofluoresc
materi
collect
nasopharynx
smear
upper
respiratori
aspir
assess
antibodi
mycoplasma
chlamydophila
class
igm
igg
comparison
antibodi
level
acut
phase
diseas
convalesc
children
difficult
collect
reliabl
materi
microbiolog
analysi
low
noninvas
manner
retain
repres
lower
respiratori
tract
flora
nasal
smear
cultur
use
establish
etiolog
pneumonia
pathogen
grown
manner
includ
physiolog
flora
well
flora
could
potenti
caus
pneumonia
hand
microbiolog
cultur
need
secur
antibiot
therapi
commenc
imposs
mani
case
solut
problem
detect
microbi
genet
materi
exampl
materi
acquir
nasal
smear
cultur
howev
import
rememb
pcr
result
may
posit
case
persist
infect
pathogen
prolong
shed
observ
even
month
sinc
begin
infect
anoth
problem
tradit
bacteri
cultur
insuffici
establish
etiolog
mainli
due
signific
particip
virus
etiopathogenesi
infect
especi
concern
children
first
year
life
viral
infect
may
respons
even
pneumonia
case
current
use
molecular
examin
enabl
quick
identif
numer
pathogen
detect
influenza
viru
pcr
wide
accept
util
method
confirm
infect
also
true
respiratori
syncyti
viru
rsv
main
drawback
test
detect
singl
pathogen
necess
request
everi
examin
separ
collect
sampl
analysi
multipl
time
make
decis
concern
select
pathogen
analysi
test
panel
use
establish
presenc
import
bacteri
viral
pathogen
enabl
simultan
detect
signific
etiolog
factor
separ
problem
apart
accept
viral
etiolog
pneumonia
may
also
caus
new
virus
human
metapneumoviru
hmpv
human
coronaviru
bocaviru
molecular
techniqu
sensit
capabl
diagnos
virus
prompt
accur
diagnosi
import
infect
control
surveil
patient
cohort
treatment
choic
avoid
antibiot
previou
experi
use
multiplex
realtim
pcr
test
popul
children
limit
aim
studi
assess
use
multiplex
realtim
pcr
test
diagnost
therapeut
process
children
hospit
due
pneumonia
burden
comorbid
data
present
percentag
median
rang
mean
standard
deviat
interv
data
analyz
test
sinc
data
follow
normal
distribut
kolmogorovsmirnov
test
nomin
data
analyz
chisquar
test
independ
case
zero
observ
frequenc
exact
fisherfreemanhalton
test
use
data
analyz
use
statist
packag
statistica
statsoft
inc
statxact
cytel
test
consid
signific
p
studi
group
includ
patient
boy
girl
averag
age
group
month
presenc
comorbid
establish
children
includ
respiratori
system
diseas
case
cardiac
diseas
case
neurolog
diseas
case
neoplast
diseas
case
immunosuppress
identifi
patient
detail
provid
tabl
posit
test
result
achiev
patient
presenc
viral
factor
establish
sampl
posit
result
bacteri
factor
found
sampl
posit
result
presenc
genet
materi
singl
pathogen
found
children
posit
result
detail
analysi
present
tabl
basi
obtain
result
group
patient
establish
viral
pneumonia
patientsbacteri
pneumonia
patientspneumonia
mix
etiolog
patientspneumocysti
pneumonia
patientspneumonia
unestablish
etiolog
patientswhen
compar
group
differ
found
term
age
day
materi
collect
relat
hospit
time
necess
icu
stay
radiolog
imag
analysi
suffici
unambigu
diagnos
etiolog
pneumonia
respiratori
infect
presenc
airflow
obstruct
significantli
higher
patient
viral
etiolog
p
admiss
children
neg
realtim
pcr
result
elev
procalcitonin
level
proport
significantli
higher
compar
patient
establish
etiolog
p
differ
observ
compar
proport
patient
markedli
elev
crp
level
mgdl
preval
increas
procalcitonin
level
ngml
higher
patient
without
establish
etiolog
differ
statist
signific
differ
observ
compar
number
patient
increas
crp
level
airflow
obstruct
found
patient
viral
etiolog
pneumonia
differ
statist
signific
p
frequent
identifi
pathogen
rsv
children
rhinoviru
rh
found
patient
adenoviru
adv
cytomegaloviru
cmv
pneumocysti
jiroveci
pnp
pure
bacteri
etiolog
establish
patient
detail
present
figur
relat
found
age
presenc
individu
microorgan
infect
rsv
etiolog
frequent
younger
children
median
age
month
versu
month
p
airflow
obstruct
symptom
also
frequent
group
p
children
age
one
domin
pathogen
rsv
found
patient
age
group
posit
result
rsv
occur
children
first
year
life
blood
cultur
perform
children
case
steril
bacteri
flora
growth
occur
case
case
patholog
aureu
serratia
sp
e
coli
respiratori
aspir
cultur
perform
children
steril
physiolog
respiratori
tract
flora
growth
achiev
case
patholog
case
result
confirm
multiplex
realtim
pcr
test
nasal
smear
cultur
perform
children
steril
presenc
patholog
flora
found
case
case
result
confirm
multiplex
realtim
pcr
test
detail
result
microbiolog
analys
patient
least
one
posit
microbiolog
result
present
tabl
group
children
neg
result
multiplex
pcr
test
blood
cultur
posit
case
e
coli
serratia
aureu
tracheal
aspir
cultur
posit
patholog
flora
grown
nasal
smear
cultur
indic
presenc
pathogen
flora
case
see
detail
tabl
test
result
enabl
implement
target
therapi
patient
detail
present
tabl
acquir
result
confirm
use
multiplex
realtim
pcr
test
establish
etiolog
sever
pneumonia
hospit
children
probabl
etiolog
pneumonia
diagnos
children
use
method
exclus
children
neoplast
diseas
group
percentag
increas
similar
percentag
posit
result
often
encount
literatur
bierbaum
et
al
achiev
posit
result
multiplex
realtim
pcr
test
detect
viral
factor
case
group
children
age
six
symptom
respiratori
tract
infect
domin
pathogen
rsv
studi
conduct
mengel
et
al
group
children
symptom
respiratori
infect
collect
sampl
posit
rh
rsv
influenza
viru
frequent
pathogen
analysi
found
signific
particip
rsv
howev
patient
pneumonia
underw
analysi
gener
lower
particip
viral
factor
comparison
research
mengel
like
result
fact
studi
includ
number
bacteri
factor
abovement
work
take
consider
swiss
studi
conduct
ceveymacherel
et
al
etiolog
pneumonia
case
diagnos
children
age
five
use
pcr
method
result
point
presenc
virus
bacteria
children
etiolog
mix
italian
studi
within
group
age
year
etiolog
establish
case
use
molecular
analysi
presenc
virus
reveal
sampl
bacteria
sampl
mix
etiolog
present
children
mengel
et
al
demonstr
infect
caus
one
viru
common
occur
children
includ
studi
sensit
viru
detect
multiplex
realtim
pcr
method
high
reach
almost
genet
materi
sever
pathogen
reveal
use
pcr
method
may
result
simultan
infect
caus
two
pathogen
infect
patient
alreadi
carrier
anoth
pathogen
may
also
result
establish
presenc
viral
genet
materi
previou
infect
socal
viru
shed
estim
etiolog
pneumonia
mix
children
work
point
relat
type
viral
factor
risk
coinfect
martic
et
al
found
coinfect
differ
pathogen
infect
caus
adenoviru
high
percentag
coinfect
studi
may
explain
specif
studi
group
major
children
burden
presenc
chronic
diseas
patient
immunosuppress
presenc
bacteri
coinfect
frequent
viral
etiolog
pneumonia
howev
bacteria
alway
respons
activ
infect
children
pneumonia
establish
presenc
virus
upper
respiratori
tract
consid
probabl
etiolog
factor
posit
result
may
also
achiev
individu
temporari
asymptomat
carrier
state
convalesc
previou
infect
therefor
necessari
remain
cautiou
interpret
examin
result
clinic
signific
human
rv
rna
detect
respiratori
sampl
remain
unclear
pcr
method
enabl
unambigu
differenti
infect
carriag
even
use
quantit
method
need
state
howev
compar
studi
carriag
significantli
often
indic
presenc
pneumonia
children
pneumonia
compar
healthi
popul
avail
literatur
contain
report
state
higher
number
virus
usual
associ
milder
diseas
cours
except
coinfect
rsv
hmpv
infect
type
character
intensifi
obstruct
symptom
group
children
infect
caus
mix
pathogen
differ
children
infect
caus
singl
pathogen
term
sever
diseas
cours
intens
inflammatori
reaction
high
percentag
posit
result
examin
detect
viral
genet
materi
point
signific
virus
occurr
pneumonia
children
literatur
indic
virus
may
respons
major
pneumonia
case
children
group
case
hospit
children
patient
receiv
outpati
antibiot
therapi
continu
inpati
care
case
therefor
sampl
collect
antibiot
therapi
fifth
day
averag
henc
possibl
complet
exclud
presenc
bacteri
factor
identifi
upper
respiratori
tract
later
due
ongo
antibiot
therapi
may
explain
rel
low
percentag
bacteri
genet
materi
detect
group
analyz
current
guidelin
recommend
use
antibiot
therapi
children
hospit
due
pneumonia
lack
clinic
improv
despit
applic
broadspectrum
antibiot
therapi
may
suggest
viral
caus
infect
studi
group
uniqu
due
high
particip
patient
comorbid
immunosuppress
patient
higher
risk
sever
cours
infect
prolong
hospit
diagnosi
viral
etiolog
infect
enabl
moder
use
antibiot
allow
emphasi
symptomat
treatment
benefici
patient
virus
easili
transmit
patient
patient
advanc
infect
control
method
critic
control
spread
virus
rsv
turn
frequent
detect
pathogen
especi
group
children
age
one
moreov
frequent
identifi
pathogen
children
risk
group
rsv
caus
infect
sever
cours
character
high
infecti
diagnos
rsv
etiolog
factor
enabl
isol
cohort
patient
order
reduc
spread
infect
implement
recommend
manag
sever
obstruct
research
current
conduct
implement
antivir
drug
effect
previous
use
ribavirin
case
viral
infect
influenza
establish
etiolog
factor
enabl
implement
specif
treatment
studi
group
singl
case
influenza
found
year
studi
conduct
epidem
year
molecular
test
detect
influenza
viru
wide
appli
use
epidem
season
import
rememb
diseas
may
occur
also
outsid
period
certain
situat
may
difficult
select
diagnost
test
basi
symptom
moreov
case
influenza
time
treatment
implement
crucial
therefor
includ
influenza
standard
diagnost
set
prevent
omiss
import
infect
factor
conduct
analysi
show
limit
use
tradit
microbiolog
examin
diagnost
process
pneumonia
take
blood
cultur
also
consid
standard
sever
pneumonia
use
signific
group
patient
radiolog
confirm
pneumonia
esposito
reveal
presenc
pneumonia
case
diagnos
base
posit
result
realtim
pcr
test
conduct
materi
collect
respiratori
tract
posit
result
blood
cultur
present
case
nasopharyng
swab
cultur
often
show
flora
growth
may
constitut
colon
analysi
tradit
microbiolog
examin
reveal
presenc
potenti
pathogen
bacteria
materi
collect
children
case
agreement
result
multiplex
realtim
pcr
test
patient
possibl
assess
agreement
research
method
due
fact
ftd
respiratori
pathogen
test
microorgan
pseudomona
aeruginosa
escherichia
coli
serratia
sp
detect
major
previou
work
assess
result
multiplex
realtim
pcr
test
conduct
admiss
room
patient
report
respiratori
symptom
cost
associ
test
difficult
use
manner
daili
practic
mention
analys
seem
epidemiolog
natur
work
made
attempt
assess
use
test
conduct
hospit
children
sever
pneumonia
respond
standard
therapi
group
patient
benefit
appli
treatment
satisfactori
relat
diagnost
cost
incur
confirm
viral
etiolog
import
especi
group
children
risk
sever
cours
infect
uniqu
group
patient
constitut
children
burden
comorbid
immunosuppress
marrow
stem
cell
transplant
implement
target
treatment
taken
consider
use
modern
antivir
drug
well
step
isol
reduct
immunosuppress
guidelin
neutropenia
manag
strongli
advis
isol
patient
document
respiratori
virus
symptom
resolv
limit
studi
collect
heterogen
group
patient
differ
indic
test
differ
comorbid
chronic
diseas
number
patient
number
specimen
small
perform
elabor
statist
analysi
sampl
collect
microbiolog
cultur
incomplet
exact
time
sampl
collect
rel
antibiot
administr
accur
document
similar
problem
describ
clinic
studi
subject
topic
analysi
demonstr
coinfect
virus
common
sever
lung
infect
children
comorbid
multiplex
realtim
pcr
test
prove
use
establish
etiolog
pneumonia
hospit
children
tradit
microbiolog
examin
wide
use
applic
diagnost
process
date
